发明名称 |
ERHÖHTE EXPRESSION VON T- ZELLENREZEPTORVERMITTELTER TUMORNEKROSEFAKTORSUPERFAMILIE UND CHEMOKIN-MRNA IN PERIPHEREN BLUT LEUKOZYTEN BEI PATIENTEN MIT MORBUS& XA;CROHN |
摘要 |
A method is disclosed for determining whether a human having Crohn's disease is likely to respond to a therapy targeting a TNFSF member or a cytokine by measuring the level of certain mRNAs in response to a stimulus. A method of evaluating the effectiveness of a Crohn's disease therapy in a human is also disclosed. Furthermore, a method of screening compounds for use in the treatment of Crohn's disease is disclosed. A method of monitoring the disease state over time in Crohn's disease patients is also disclosed. |
申请公布号 |
AT518011(T) |
申请公布日期 |
2011.08.15 |
申请号 |
AT20070755012T |
申请日期 |
2007.04.05 |
申请人 |
HITACHI CHEMICAL COMPANY, LTD.;HITACHI CHEMICAL RESEARCH CENTER, INC.;CEDARS-SINAI MEDICAL CENTER |
发明人 |
MITSUHASHI, MASATO;TARGAN, STEPHAN |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|